04:11 PM EDT, 06/03/2024 (MT Newswires) -- Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer, on May 30, 2024, sold 4,600 shares in Vertex Pharmaceuticals ( VRTX ) for $2,033,159. Following the Form 4 filing with the SEC, Tatsis has control over a total of 51,273 shares of the company, with 51,273 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/875320/000087532024000166/xslF345X03/wk-form4_1717445345.xml